Deutsch - Impulse Dynamics
  • Home
  • Patienten
  • Medizinische Fachkräfte
    • Indikationen gemäß CE-Kennzeichnung & Patientenselektion
    • Verfahren und Wirkungsweise
    • Publikationen
    • Gebrauchsanweisun-gen und Handbücher
  • Unternehmen
    • News
    • Governance – Grundsätze der Unternehmens-führung
    • Informations-quellen
    • Clinical Trials
    • Karriere
    • Kontakt
  • Einen Arzt finden
  • Region
    • US
    • DE
    • Global
Select Page

Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase

by Impulse Dynamics | Jun 26, 2025 | News and Events, Press Releases

PRESS RELEASE First phase of enrollment of single device for CCM® and ICD therapy completeMARLTON, N.J., April 28, 2025 (GLOBE NEWSWIRE) — Impulse Dynamics® plc, a global medical device company dedicated to improving the lives of people with heart failure (HF), is...

Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure

by Impulse Dynamics | Jun 26, 2025 | News and Events, Press Releases

PRESS RELEASE CCM therapy is now indicated for symptomatic heart failure patients with diastolic or systolic ventricular dysfunction, offering a broader range of patients a new option for improving quality of life and reducing heart failure hospitalization MARLTON,...

Impulse Dynamics Expands Executive Leadership Team

by Impulse Dynamics | Jun 26, 2025 | News and Events, Press Releases

PRESS RELEASE Extensive depth of experience comes with new leaders – Chief Operating Officer,Chief Financial Officer, Chief Administrative Officer and Chief Science and Strategy Officer MARLTON, N.J., September 24, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a...

Impulse Dynamics Surpasses 10,000 Patients Benefiting from CCM® Therapy for Heart Failure

by Impulse Dynamics | Jun 26, 2025 | News and Events, Press Releases

PRESS RELEASE Milestone Highlights Transformative SymptomManagement for Patients Living with Heart FailureMARLTON, N.J., May 13, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure...

Impulse Dynamics Completes $136M Financing Round

by Impulse Dynamics | Jun 26, 2025 | News and Events, Press Releases

PRESS RELEASE Continued Progress Earns Financing to AccelerateCommercial Growth and Advancing PipelineMARLTON, N.J., February 14, 2024 (GLOBE NEWSWIRE) — Impulse Dynamics plc, a global medical device company dedicated to improving the lives of people with heart...

Impulse Dynamics Receives Full-Body MRI-Conditional Approval for Optimizer Smart Mini System

by Impulse Dynamics | Jun 26, 2025 | News and Events, Press Releases

PRESS RELEASE Reflecting Company Commitment to Innovation in Support of Patient NeedMARLTON, N.J., October 30, 2023 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), announced today...
« Older Entries

Recent Posts

  • Impulse Dynamics®’ INTEGRA-D Trial Completes Efficacy Phase
  • Impulse Dynamics Receives European CE Mark For Expanded Indication For Diastolic Heart Failure
  • Impulse Dynamics Expands Executive Leadership Team
  • Impulse Dynamics Surpasses 10,000 Patients Benefiting from CCM® Therapy for Heart Failure
  • Impulse Dynamics Completes $136M Financing Round

Recent Comments

  • 1amphibious on Impulse Dynamics Announces Chief Financial Officer Transition

Archives

  • June 2025
  • August 2022
  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • January 2022
  • February 2021
  • January 2021
  • April 2020
  • March 2020
  • December 2019
  • November 2019
  • October 2019
  • August 2019
  • March 2019
  • May 2018
  • December 2017
  • August 2017
  • May 2017
  • March 2017
  • September 2016
  • May 2016
  • March 2016
  • January 2016
  • November 2015
  • August 2015
  • July 2015
  • January 2015
  • December 2014

Categories

  • News and Events
  • Press Releases
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Like most websites on the internet, this website uses cookies. By using our website, you agree to our Cookie Policy. I Accept